0001555280-20-000318.txt : 20201117 0001555280-20-000318.hdr.sgml : 20201117 20201117163031 ACCESSION NUMBER: 0001555280-20-000318 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201113 FILED AS OF DATE: 20201117 DATE AS OF CHANGE: 20201117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alaix Juan Ramon CENTRAL INDEX KEY: 0001567824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 201321518 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 4 1 wf-form4_160564861834659.xml FORM 4 X0306 4 2020-11-13 0 0001555280 Zoetis Inc. ZTS 0001567824 Alaix Juan Ramon C/O ZOETIS INC. 10 SYLVAN WAY PARSIPPANY NJ 07054 1 0 0 0 Common Stock 2020-11-13 4 S 0 69319 165.29 D 26694 D Common Stock 2020-11-13 4 S 0 22428 165.99 D 4266 D The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.59 to $165.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.59 to $166.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Katherine H. Walden, as Attorney-in-Fact 2020-11-17